Search company, investor...

Compare Epeius Biotechnologies vs Targeted Genetics

Customers evaluate the quality of Epeius Biotechnologies's products using the following success metrics.

Overview

Epeius Biotechnologies is based in United States

Scientists at Epeius Biotechnologies have developed a targeted delivery system (TDS) that can transport genes or other therapeutic agents directly to diseased areas in the body. This pathotropic, or disease-seeking, technology has enabled the company to develop Rexin-G, a tumor-targeted, injectable gene delivery system that has demonstrated remarkable safety and single-agent efficacy in clinical trials internationally. Rexin-G is currently in clinical trials for pancreatic cancer in the U.S. ƒƒ‚ƒš‚" where it has achieved FDA orphan drug status ƒƒ‚ƒš‚" and has accelerated approval in the Philippines for the treatment of all solid tumors that are resistant to standard chemotherapy. The company's international clinical outreach with Rexin-G has enabled us to expedite further demonstrations that Rexin-G is highly active in a broad spectrum of chemo-resistant tumor types with efficacy and excellent safety profiles. The company are a biopharmaceutical company focused on expanding the therapeutic utility and commercialization of the company's pathotropic approach to disease treatment through internal development and commercialization of the company's oncology products and cancer vaccines, and through strategic partnerships in additional areas of oncology, immunology, cardiovascular, ocular, and wound healing applications, precision targeted diagnostics, and stem cell technologies.

Targeted Genetics is 35 yrs old and is based in United States.

Targeted Genetics Corp. is a leader in gene delivery technology and in the development of therapeutic products based on gene delivery.

Country

United States

Demo Video

Demo not available because Epeius Biotechnologies has not claimed their profile.

Work for Epeius Biotechnologies? Show off your product.

Demo not available because Targeted Genetics has not claimed their profile.

Work for Targeted Genetics? Show off your product.

Leadership

H. Stewart Parker (Chief Executive Officer)

See all 2 people

Funding

Targeted Genetics last raised $19.46M on 6/8/2007.

Investors

OrbiMed Advisors, Heights Capital Management

See all 5 investors

Product

Benefits

Products

Customers

Known Partners

Why They Buy

Information not available because Epeius Biotechnologies has not claimed their profile.

Work for Epeius Biotechnologies? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Epeius Biotechnologies?

Claim your profile now.

Information not available because Targeted Genetics has not claimed their profile.

Work for Targeted Genetics? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Targeted Genetics?

Claim your profile now.